meta
|
Preg
- medecines during pregnancy KB
Search
Lurasidone
Overall results
Study description
Excluded studies
Table
Graphic
auto
during pregnancy (anytime or not specified)
1st trimester
2nd trimester
3rd trimester
2nd and/or 3rd trimester
throughout pregnancy
early pregnancy
days before delivery
late pregnancy
preconception-only
periconceptional
preconceptional for kinetic reason
at least 1st trimester
3 months (or more) before pregnancy or during pregnancy
1st and 2nd trimester
3 months or more before pregnancy or1st trimester
Whatever the period exposition
individual studies
Outcome
TE
95% CI
n cases
n exposed
k
Pub. bias
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)
Cohen, 2023
1
1.32
[
0.38
; 4.60]
19
137
not evaluable
Major congenital malformations
Cohen, 2023
1
1.32
[
0.38
; 4.60]
19
137
not evaluable
Growth parameters and prematurity
Preterm (< 37 weeks)
Kernizan (Controls unexposed, sick), 2024
1
0.44
[
0.14
; 1.36]
46
25
not evaluable
Maternal consequences
Caesarean
Kernizan (Controls unexposed, sick), 2024
1
0.92
[
0.37
; 2.29]
55
25
not evaluable
Neonatal disorders
Neonatal medical care
Kernizan (Controls unexposed, sick), 2024
1
0.84
[
0.31
; 2.26]
44
25
not evaluable
Withdrawal syndrome / Neonatal abstinence syndrome / Poor neonatal adaptation
Kernizan, 2019
1
0.34
[
0.04
; 2.67]
17
24
not evaluable
Intrauterine deaths
Intrauterine deaths (as a whole or unspecified)
Kernizan, 2019
1
0.64
[
0.03
; 12.29]
4
24
not evaluable
0.0
20.0
1.0
